Vilaprisan for the treatment of symptomatic endometriosis: results from a terminated phase 2b randomized controlled trial

Objective: To evaluate the efficacy and safety of 2 doses of vilaprisan vs. placebo in participants with symptomatic endometriosis. Design: Multicenter, randomized, double-blind, placebo-controlled, parallel-group phase 2b trial (NCT03573336). The initially planned sample size was 315 patients. Recr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hugh S. Taylor, M.D (Autor), Liying Dong, M.D., Ph.D (Autor), Johanna Haikonen, M.D (Autor), Peter Oppelt, M.D (Autor), Karl Tamussino, M.D (Autor), Rene Wenzl, M.D., Ph.D (Autor), Thomas Faustmann, M.D (Autor), Esther Groettrup-Wolfers, M.D., Ph.D (Autor), Xiaowei Ren, Ph.D (Autor), Christian Seitz, M.D., Ph.D (Autor)
Format: Llibre
Publicat: Elsevier, 2024-06-01T00:00:00Z.
Matèries:
Accés en línia:Connect to this object online.
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Internet

Connect to this object online.

3rd Floor Main Library

Detall dels fons de 3rd Floor Main Library
Signatura: A1234.567
Còpia 1 Disponible